Spectrum of ultrasound findings in patients with history of breast conservative treatment

Fatemeh Shakki Katouli; Leila Bayani; Fahimeh Azizinik; Somayeh Fathi; Akram Seifollahi; Fatemeh Zare Bozorgabadi

doi:10.1002/jcu.23524

Spectrum of ultrasound findings in patients with history of breast conservative treatment

J Clin Ultrasound. 2023 Oct;51(8):1381-1389. doi: 10.1002/jcu.23524. Epub 2023 Aug 1.

Authors

Fatemeh Shakki Katouli^{1

2}, Leila Bayani², Fahimeh Azizinik^{1

3}, Somayeh Fathi^{1

4}, Akram Seifollahi⁵, Fatemeh Zare Bozorgabadi^{1

6}

Affiliations

¹ Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.
² Department of Radiology, Arash Women Hospital, Tehran University of Medical Sciences, Tehran, Iran.
³ Department of Radiology, Amiralam and Yas Hospitals, Tehran University of Medical Sciences, Tehran, Iran.
⁴ Department of Radiology, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Pathology Department, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Department of Radiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 37526634
DOI: 10.1002/jcu.23524

Abstract

Breast conservative treatment (BCT) is currently accepted as the standard treatment option for breast cancer. Targeted ultrasound helps detect recurrent lesions, postoperative changes, and scarring tissue. In this pictorial essay, we review the ultrasound features of benign (seroma, hematoma, fat necrosis, traumatic neuroma, fibrosis/scarring) and malignant (recurrence, new primary cancer) causes of palpable lumps after BCT and provide images from our patients to illustrate some typical findings of common pathologies. Ultrasound, especially as an adjunct to mammography, can make a specific diagnosis in most cases.

Keywords: breast cancer; breast conservative treatment; recurrence; ultrasound.

Publication types

Review